IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 144 filers reported holding IDEAYA BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,485,144 | +19.6% | 499,820 | +4.2% | 4.20% | +36.1% |
| Q2 2023 | $11,275,770 | +75.3% | 479,820 | +2.4% | 3.08% | +59.9% |
| Q1 2023 | $6,430,555 | -24.4% | 468,358 | 0.0% | 1.93% | -19.6% |
| Q4 2022 | $8,510,065 | +5.9% | 468,358 | -13.0% | 2.40% | +10.9% |
| Q3 2022 | $8,035,000 | +6.1% | 538,561 | -1.8% | 2.16% | +4.8% |
| Q2 2022 | $7,570,000 | +38.0% | 548,561 | +11.9% | 2.06% | +44.4% |
| Q1 2022 | $5,484,000 | -49.6% | 490,061 | +6.5% | 1.43% | -47.8% |
| Q4 2021 | $10,876,000 | -7.3% | 460,061 | 0.0% | 2.74% | -12.1% |
| Q3 2021 | $11,727,000 | +68.4% | 460,061 | +38.7% | 3.11% | +113.7% |
| Q2 2021 | $6,962,000 | -10.7% | 331,661 | 0.0% | 1.46% | -21.3% |
| Q1 2021 | $7,794,000 | +67.9% | 331,661 | 0.0% | 1.85% | +33.8% |
| Q4 2020 | $4,643,000 | +11.4% | 331,661 | 0.0% | 1.38% | +2.1% |
| Q3 2020 | $4,166,000 | – | 331,661 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |